Drug Side Effects
Search
CYSTADENOCARCINOMA OVARY
CYSTADENOCARCINOMA OVARY
was reported 6 times
CYSTADENOCARCINOMA OVARY is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Interleukin-17A Antagonist [EPC]
1
0.0000
1
Anti-IgE [EPC]
1
0.0000
2
Factor Xa Inhibitor [EPC]
1
0.0000
3
Progestin [EPC]
1
0.0000
4
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
5
Corticosteroid [EPC]
1
0.0000